Class Action Alert: Actinium Pharmaceuticals, Inc. (ATNM)
On April 21, 2025, The Gross Law Firm announced a class action lawsuit against Actinium Pharmaceuticals, Inc. (NYSE: ATNM) that affects shareholders who acquired shares during the period from October 31, 2022, to August 2, 2024. If you are an investor in ATNM, it is critical to be aware of the upcoming May 27, 2025, deadline for participating in this legal action.
Allegations Against Actinium
The allegations within the complaint are serious, claiming that Actinium Pharmaceuticals made actively misleading statements regarding their Phase 3 Sierra trial data. Specifically, it asserts that the results presented to the FDA for their targeted radiotherapy, Iomab-B, were not merely optimistic; rather, they were potentially fabricated or exaggerated to mislead investors about the drug's viability for approval.
The FDA's guidelines for the acceptance of such applications are stringent, and the lawsuit indicates that Actinium's attempts may not have met these requirements. As such, this led to a significant misrepresentation of the company’s prospects, which might have inflated stock prices unfairly, causing potential losses for shareholders as reality set back in.
What This Means for Shareholders
Actinium's shareholders who experienced financial losses during this timeframe are encouraged to register their information with The Gross Law Firm, as this class action does not require them to be the lead plaintiff to receive potential compensation. Once registered, shareholders will also benefit from a portfolio monitoring system designed to keep them informed throughout the lifecycle of the case.
The Gross Law Firm specializes in protecting investors’ rights, particularly those affected by deceptive or fraudulent actions of public companies. Their commitment to transparency and ethical practices in the corporate landscape is evident, making them a trustworthy ally for shareholders navigating potentially complex legal matters.
Next Steps for Interested Parties
To register for this class action lawsuit, shareholders must act quickly. The deadline to register is fast approaching, and it is advisable to visit the following link to submit your information:
Register Here.
Contact Information
For further assistance, you can reach The Gross Law Firm via:
- - Address: 15 West 38th Street, 12th Floor, New York, NY 10018
- - Phone: (646) 453-8903
- - Email: [email protected]
As we draw nearer to the May 2025 deadline, it’s crucial for affected shareholders to make their voices heard and protect their financial interests. By participating, investors can take a stand against potentially misleading practices that compromise both the integrity of the market and the investors’ trust.
Stay informed and don’t miss this opportunity to assist in holding corporations accountable for their actions.